Erratum to: Lenalidomide in patients with cisplatin-refractory and multiply relapsed germ cell tumors

被引：0
|
作者：
Karin Oechsle
Carsten Bokemeyer
Friedemann Honecker
机构：
[1] University Medical Center Eppendorf,Departments of Oncology, Hematology, Bone Marrow Transplantation and Pneumology
来源：
Journal of Cancer Research and Clinical Oncology | 2010年 / 136卷 / 1期
关键词：
D O I：
10.1007/s00432-009-0697-y
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Prognostic factors in patients with relapsed or primary refractory germ cell tumors
    Rejlekova, K.
    Mego, M.
    Sycova-Mila, Z.
    Obertova, J.
    Rajec, J.
    Salek, T.
    Mardiak, J.
    NEOPLASMA, 2009, 56 (03) : 215 - 223
  • [42] Salvage chemotherapy with paclitaxel and gemcitabine plus nedaplatin (TGN) as part of multidisciplinary therapy in patients with heavily pretreated cisplatin-refractory germ cell tumors
    Takumi Shiraishi
    Terukazu Nakamura
    Kazuya Mikami
    Natsuki Takaha
    Akihiro Kawauchi
    Tsuneharu Miki
    International Journal of Clinical Oncology, 2009, 14 : 436 - 441
  • [43] Phase II trial of sunitinib in patients with relapsed or refractory germ cell tumors
    Darren R. Feldman
    Stefan Turkula
    Michelle S. Ginsberg
    Nicole Ishill
    Sujata Patil
    Maryann Carousso
    George J. Bosl
    Robert J. Motzer
    Investigational New Drugs, 2010, 28 : 523 - 528
  • [44] Phase II trial of sunitinib in patients with relapsed or refractory germ cell tumors
    Feldman, Darren R.
    Turkula, Stefan
    Ginsberg, Michelle S.
    Ishill, Nicole
    Patil, Sujata
    Carousso, Maryann
    Bosl, George J.
    Motzer, Robert J.
    INVESTIGATIONAL NEW DRUGS, 2010, 28 (04) : 523 - 528
  • [45] Salvage chemotherapy with paclitaxel and gemcitabine plus nedaplatin (TGN) as part of multidisciplinary therapy in patients with heavily pretreated cisplatin-refractory germ cell tumors
    Shiraishi, Takumi
    Nakamura, Terukazu
    Mikami, Kazuya
    Takaha, Natsuki
    Kawauchi, Akihiro
    Miki, Tsuneharu
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2009, 14 (05) : 436 - 441
  • [46] Phase II study of oxaliplatin and gemcitabine salvage chemotherapy in patients with cisplatin-refractory nonseminomatous germ cell tumor
    De Giorgi, Ugo
    Rosti, Giovanni
    Aieta, Michele
    Testore, Franco
    Burattini, Luciano
    Fornarini, Giuseppe
    Naglieri, Emanuele
    Lo Re, Giovanni
    Zumaglini, Federica
    Marangolo, Maurizio
    EUROPEAN UROLOGY, 2006, 50 (05) : 1032 - 1039
  • [47] Weekly gemcitabine, paclitaxel, oxaliplatin combination chemotherapy in patients with cisplatin-refractory germ cell tumor - Preliminary experience
    De Giorgi, U
    Rosti, G
    Papiani, G
    Aieta, M
    Fochessati, F
    Paoluzzi, L
    Valduga, F
    Marangolo, M
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2004, 27 (05): : 457 - 460
  • [48] Single centre experience of lenalidomide in multiply relapsed and or refractory lymphomas
    Qureshi, I.
    Saeed, M.
    Kaparou, M.
    Kanellopoulos, A.
    Murthy, V.
    Nikolousis, E.
    Kishore, B.
    Holder, K.
    Paneesha, S.
    Lovell, R.
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 173 : 91 - 92
  • [49] Paclitaxel chemotherapy in the salvage of multiply relapsed and platinum refractory germ cell tumours
    Staffurth, JN
    Nichols, J
    Huddart, RA
    Dearnaley, DP
    Horwich, A
    BRITISH JOURNAL OF CANCER, 2000, 83 : 77 - 77
  • [50] Erratum: Lenalidomide plus dexamethasone is efficacious in patients with relapsed or refractory multiple myeloma
    Nikhil C Munshi
    Constantine Mitsiades
    Paul G Richardson
    Kenneth C Anderson
    Nature Clinical Practice Oncology, 2008, 5 : 493 - 493
12345